Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| Wearable Cardioverter-Defibrillator (WCD) | The medical term. A vest with electrodes and a small monitor that watches your heart rhythm and can deliver a shock if a dangerous rhythm appears. |
| LifeVest | Brand name made by ZOLL Medical — by far the most commonly used WCD. The name is often used interchangeably with 'WCD' in the United States. |
| ASSURE WCD | Brand name made by Kestra Medical. A newer-generation WCD with comparable function to LifeVest. Sometimes prescribed depending on insurance or institutional preference. |
| Sudden cardiac arrest (SCA) | The condition the WCD is designed to prevent. The heart suddenly stops pumping due to a dangerous rhythm. Without treatment within minutes, SCA is fatal. |
| Ventricular tachycardia (VT) | A dangerous fast rhythm starting in the bottom chambers of the heart. If sustained, it can degenerate into ventricular fibrillation. |
| Ventricular fibrillation (VF) | A chaotic heart rhythm — the heart quivers and cannot pump blood. The shock is designed to convert VT or VF back to a normal rhythm. |
| Ejection fraction (EF) | How much blood the heart pumps out with each beat. Normal is 55-70%. EF below 35% raises the risk of sudden cardiac arrest — a common WCD indication. |
What Is the Wearable Defibrillator (LifeVest)?
- The WCD is a vest worn under your clothes that continuously monitors your heart rhythm. If it detects a life-threatening rhythm and you do not respond to its alarms, it delivers an automatic shock — like a defibrillator that lives on your body.
- It is used as TEMPORARY protection — typically 30 to 90 days — while we determine whether your heart will recover, whether you need a permanent implantable defibrillator (ICD), or while you wait for an ICD implant.
- Common indications include: recent heart attack with EF <=35% (during the 40-90 day waiting period before ICD), newly diagnosed cardiomyopathy with very low EF, myocarditis, or after an infected ICD is removed.
- It does NOT pace slow rhythms. It is designed only to shock fast, dangerous rhythms (VT/VF). For slow-rhythm protection, a different device is needed.
- It is portable, wearable 24/7 except for brief showers, and does not require surgery. You go home in it and live your normal life while it watches.
Why It Matters
- Sudden cardiac arrest kills about 350,000 Americans every year. Most occur outside hospitals, and survival without immediate defibrillation is under 10%.
- Patients in the first 90 days after a major heart event (heart attack, new cardiomyopathy, myocarditis) have a higher-than-baseline risk of dangerous arrhythmias — but their heart may also recover, making a permanent device premature.
- The WCD bridges this gap. It provides defibrillator-level protection without committing you to a lifelong implant. About 75% of patients with EF <=35% have their function recover within 90 days and avoid a permanent ICD altogether.
- The VEST trial (NEJM 2018) showed WCD did not reduce arrhythmic death post-MI, though all-cause mortality was lower. Patient selection and consistent wear matter — protection only works when the vest is on.
- Daily wear time is the single most important factor for benefit. Wearing the device less than 14 hours per day substantially reduces protection. Modern devices average >22 hours/day in compliant patients.
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- The device is fitted by a certified ZOLL or Kestra representative — usually in the hospital before discharge or in our office. Fitting takes 30-60 minutes including patient and family education.
- Wear the vest 24 hours a day, removing only for a brief shower (10-15 minutes maximum). Charge one battery while wearing the other so you always have a full charge.
- If the device detects a dangerous rhythm, it gives a series of escalating alarms — vibration, then soft siren, then loud siren and voice prompt — over 25-30 seconds. If you are awake and feel fine, press BOTH response buttons together to abort the shock.
- If you do not respond (because you are unconscious from the arrhythmia), the device automatically delivers a 75-150 joule shock. You will not remember it. Most appropriate shocks succeed on the first attempt.
- After any alarm — whether you got a shock or pressed the buttons — call us immediately. Even a stopped alarm is important information about your heart rhythm.
- Follow-up visits typically occur every 2-4 weeks. We download the rhythm data from the device, review any events, and decide whether to continue WCD, transition to an ICD, or stop the vest if your heart has recovered.
- Most patients stop the WCD at 90 days. Earlier stopping happens if your EF recovers and stays above 35%. Some patients transition to permanent ICD if EF remains low.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Wearable Cardioverter-Defibrillator (WCD) | Skin irritation. False alarms (rare with newer devices — under 6%). Inappropriate shocks (under 1%). Requires daily charging and consistent wear (less protection if not worn). Patient compliance variable. | External protection during the high-risk window. No surgery. Removable when heart recovers. Allows reassessment of need for permanent ICD. ~98% first-shock conversion success. | Early ICD (more invasive, permanent device — only if criteria met), medical therapy alone (no rescue if a dangerous rhythm occurs), hospitalization for monitoring (impractical for 90 days). |
| Early ICD implantation (within 40 days post-MI) | Surgical risk. Lifetime device implant. ~5% inappropriate-shock rate over device lifetime. Lead complications. Battery replacement every 5-8 years. | Permanent protection. No daily wear or charging. Definitive answer for patients who clearly will not recover EF. | DINAMIT and IRIS trials showed no mortality benefit for early post-MI ICD. Guidelines DO NOT recommend ICD in the first 40 days post-MI. WCD is the preferred bridge. |
| Medical therapy without WCD or ICD (beta-blocker + ACEi/ARB + MRA + SGLT2i) | No defibrillator protection if a dangerous rhythm occurs. Outcomes depend entirely on EF recovery. | Optimal medical therapy reduces arrhythmia risk and improves EF in many patients. Reasonable for patients with mildly reduced EF or low-risk profile. | WCD adds rescue capability if rhythm occurs, ICD if EF stays <=35% after 90 days, no additional therapy if EF normalizes. |
| Permanent ICD after waiting period (>40 days post-MI or >90 days for new cardiomyopathy) | Surgical implant. Long-term complications. Lifetime device commitment. | Class I indication for primary prevention if EF remains <=35% on optimal medical therapy. Substantial mortality reduction (SCD-HeFT, MADIT-II trials). | Continue WCD long-term (acceptable in select cases who refuse ICD), no device (no rescue protection if EF stays low). |
Common Misconceptions
| Myth | Reality |
|---|---|
| The vest will shock me by accident. | Modern WCDs have a very low inappropriate-shock rate (under 1%). The device gives multiple escalating alarms over 25-30 seconds — you have ample time to press the response buttons if you feel fine. The shock is only delivered if you do not respond, which means you are unconscious from a real dangerous rhythm. |
| I can take the vest off for a few hours and be fine. | Protection only works when the vest is on. Going below 14 hours/day of wear substantially reduces benefit. The most dangerous moments often occur unpredictably — exactly when an unprotected gap is most risky. |
| If the vest gives me a shock, I should go to the ER but it's not urgent. | Any WCD shock is an emergency. Call 911 immediately or go to the nearest ER. A shock means your heart had a dangerous rhythm. You need urgent evaluation to determine why and what comes next (often an ICD). |
| I'll be wearing this forever. | The WCD is temporary. Most patients wear it for 30-90 days while we see whether their heart function recovers. About 75% of patients improve enough that they never need a permanent ICD. |
| The vest can do everything an ICD does. | The WCD only treats fast dangerous rhythms (VT/VF). It cannot pace slow rhythms. For patients who need pacing or anti-tachycardia pacing, an ICD is required. |
| It will be too uncomfortable to sleep in. | Most patients adjust within a few days. Modern designs are lighter and more breathable than older models. The vibration alarm is designed to wake you if needed, but the device is otherwise quiet at night. |
| Showering will damage the device. | You should remove the vest for showers — but the brief uncovered window is built into the protocol. Keep showers to 10-15 minutes, put the vest back on as soon as you are dry, and never shower if you are alone unless cleared by us. |
| If my heart recovers, I never had a problem. | Recovery of EF reduces but does not eliminate future risk. Continued medical therapy, follow-up, and lifestyle management remain important. The fact that your heart needed a WCD means it is more vulnerable than average. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Skin irritation under electrodes | The most common side effect. Manage with daily skin checks, gentle cleansing, moisturizer, and electrode repositioning. Severe breakdown requires temporary device removal — call us first. |
| False alarms | Newer-generation devices have under 6% false-alarm rates. Press both response buttons together to abort. If alarms occur repeatedly, call ZOLL/Kestra support and us — the lead positioning may need adjustment. |
| Inappropriate shock | Very rare with modern devices (under 1%). Most often caused by exercise-induced rhythm artifacts or lead displacement. Call us immediately after any shock. |
| Reduced wear time | Wearing less than 14 hours/day substantially reduces protection. If you find the device intolerable, call us — solutions include different sizing, electrode repositioning, or considering early ICD if criteria are met. |
| Battery or device malfunction | Rare but does occur. Keep ZOLL/Kestra support numbers visible and call any time the device shows persistent errors. Backup batteries should always be charged. |
| Anxiety and emotional adjustment | Wearing a device that may shock you is psychologically demanding. Anxiety, sleep disturbance, and fear of activity are common in the first weeks. Support groups, counseling, and reassurance from the care team all help. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- Wear the vest 24 hours a day except for brief showers (10-15 minutes maximum).
- Keep two batteries — one in use, one charging — so you never run low on power.
- If the alarm sounds and you feel fine, press BOTH response buttons together to abort the shock. Do not press just one.
- If you get a shock or hear any alarm sequence, call 911 or come to the ER immediately afterward.
- Do not shower without someone within hearing distance.
- Do not swim, bathe, or get the device wet other than brief showering.
- Check your skin daily under the electrodes — irritation is common and usually managed with moisturizer or repositioning.
- Bring the device to every appointment so we can download the rhythm data.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Any shock from the device — call 911 immediately.
- Any alarm sequence (even if you pressed the buttons to stop it) — call us today.
- Chest pain, fainting, severe dizziness — call 911.
- New shortness of breath, leg swelling, or weight gain over 3 lb in 2 days — call us today.
- Skin breakdown or open sore under the electrodes — call us this week.
- Device error messages or persistent malfunction — call ZOLL/Kestra support AND call us.
- Difficulty wearing the device as prescribed — call us so we can troubleshoot before reducing wear time.
- Before any procedure, surgery, or imaging study — call us to confirm device safety.
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- ZOLL LifeVest — Patient Resources — Manufacturer patient site for the most commonly prescribed WCD, with daily care and troubleshooting.
- VA — LifeVest Patient Education Booklet — Plain-language patient booklet covering setup, daily wear, alarms, and emergencies.
- Cleveland Clinic — Sudden Cardiac Arrest — Background on the condition the WCD is designed to prevent.
- American Heart Association — Sudden Cardiac Arrest — AHA overview of sudden cardiac arrest, risk factors, and treatment.
Sources Used to Build This Guide
- Olgin et al — VEST: Wearable Cardioverter-Defibrillator after Myocardial Infarction (NEJM 2018) [clinical_trial] — The pivotal RCT. Showed WCD did NOT reduce arrhythmic death after recent MI in patients with EF <=35%, though all-cause mortality was reduced. Anchors honest framing of the evidence.
- Al-Khatib et al — 2017 AHA/ACC/HRS Guideline for Management of Ventricular Arrhythmias and Sudden Cardiac Death (JACC 2018) [guideline] — AHA/ACC guideline placing WCD as Class IIb option for select patients with EF <=35% during the 40-90 day waiting period post-MI or in early non-ischemic cardiomyopathy.
- Piccini et al — AHA Scientific Statement on Wearable Cardioverter-Defibrillators (Circulation 2016) [guideline] — AHA scientific statement specifically on WCD indications, evidence, and best-practice recommendations. Standard reference for clinical use.
- Chung et al — WEARIT-II Registry: Real-World Use and Effectiveness of WCDs (Circulation 2016) [clinical_trial] — Large prospective registry showing 1.4% appropriate-shock rate and 98% first-shock conversion success across diverse indications. Real-world effectiveness data.
- ZOLL LifeVest — Patient Resources [clinical] — Manufacturer patient site with device operation, wear-time guidance, alarm response, and battery care.
- VA — LifeVest Patient Education Booklet [clinical] — Veterans Affairs patient booklet with plain-language daily care, troubleshooting, and what-to-do-if-alarm-sounds guidance.
- Cleveland Clinic — Cardiac Arrest [clinical] — Background on sudden cardiac arrest — the condition WCDs are designed to prevent. Patient-friendly framing of the why.
- Kestra ASSURE WCD — IDE Trial (JACC 2024) [clinical_trial] — Recent trial of newer-generation WCD (Kestra ASSURE) showing improved wear-time (>22 hours/day) and lower false-alarm rates compared to first-generation devices.
